An Exploratory Study of Individualized Neo-antigen mRNA Cancer Vaccine InnoPCV in Advanced Solid Tumor Treatment
Clinical trial NCT06497010 · RECRUITING
Trial details
- NCT number
- NCT06497010
- Sponsor
- The Affiliated Hospital Of Guizhou Medical University
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-29
- Primary completion
- 2026-07-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.